Sunepitron
Chemical compound / From Wikipedia, the free encyclopedia
Sunepitron (developmental code name CP-93,393) is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist.[1][2] It was previously under development by Pfizer for the treatment of depression and anxiety.[3] It made it to phase III clinical trials before being discontinued.[2][3]
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | CP-93,393 |
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H23N5O2 |
Molar mass | 329.404 g·mol−1 |
3D model (JSmol) | |
|
Close